Showing posts with label panic disorder. Show all posts
Showing posts with label panic disorder. Show all posts

Thursday, September 16, 2021

Letter to the Minnesota Medical Cannabis Program on an Anxiety Indication

 




The Minnesota Medical Cannabis program is considering anxiety and panic attacks as an indication for the use of medical cannabis in this state. Like several other states, there was a reluctance to legalize or just decriminalize cannabis and the legislature constructed a medical cannabis program that is very expensive for most people, does not allow for smoked cannabis products, and generally acts like a mini-FDA - approving the use of an non-FDA approved compound that has really not been adequately studied.  The current reasons are anxiety and panic attacks and it has failed several times for these conditions. This time they have an extensive report at this link that I will be critiquing this weekend. My longstanding position on medical cannabis is that it is essentially a way to get cannabis approved to eventually legitimize legalization or to have these compounds available in lieu of legalization. In other words, it is the next best thing to legalization.  The scope of the medical cannabis arguments are not compelling and if the regulators of the state of Minnesota believe that cannabis is that safe and efficacious - why don't they just legalize it without a medical indication?  In talking with people in the medical cannabis program - cost and inability to titrate the dose (by smoking) are common problems. Surveys by the Program suggest even more problems.

What follows is my brief letter to the public comments section on this issue. If you look at all of the comments - it reminds me of the public comments section at the FDA for electroconvulsive therapy and whether additional trials would need to be done to relicense those devices.  It was clear that those comments in favor of that process outnumbered the pro-ECT comments - but the FDA overruled the naysayers. It is not clear to me that cannabis advocates will be overruled by the Minnesota Cannabis program but I will write more about that in my critique.  

Public commentaries can be submitted to this email address: 

health.cannabis.addmedicalcondition@state.mn.us

Petition comments can be read at this address: 

https://www.health.state.mn.us/people/cannabis/petitions/docs/2021/commentsmedcond.pdf

The Anxiety Disorder Review (by the MN Medical Cannabis Program) can be read at this address:

https://www.health.state.mn.us/people/cannabis/petitions/anxietyreport.html

Comments should be submitted by October 1, 2021

----------------------------------------------------------------------------------------------------------------------------

I am a Minnesota psychiatrist who has practiced for 22 years as an acute care inpatient psychiatrist followed by 10 years as an addiction psychiatrist. Before that I was a community psychiatrist in Superior, Wisconsin for 3 years at a community mental health center. I am no longer affiliated with any of those institutions and this email is based on my cumulative clinical experience.

In those 35 years of practice, I have done thousands of comprehensive psychiatric evaluations that typically include an assessment of any associated substance use disorder. One of my standard questions in those assessments is "Were you ever a daily marijuana smoker?" In following up that question I ask about the duration and why they may have stopped. The typical reason for stopping is that they started to get high anxiety and panic attacks.  Depending on the degree of euphoria from cannabis - some people continue to use it and expect that their anxiety or other symptoms can be treated so that they can continue to use it.

 As an acute care psychiatrist, I saw many people who were psychotic or manic as either the direct effect of cannabis or because it exacerbated an underlying major psychiatric disorder.  In the outpatients that I have treated cannabis was associated with chronic depression and cognitive symptoms that were often seen by the patient as evidence that they needed treatment for attention-deficit/hyperactivity disorder.  In both scenarios, cannabis use was more than a psychiatric diagnosis - it led to these patients having significant impairment in their relationships, vocational achievement, and general ability to function. Some tried to stop and developed cannabis hyperemesis syndrome or other symptoms of withdrawal. 

As part of my comprehensive evaluations, every patient I saw was also assessed for suicide and aggressive potential. Populations of people seeing psychiatrists will be biased in that direction because in many settings suicidal and aggressive thinking is why they are scheduled to see us.  There is a clear link between cannabis use and increased suicidal thinking.  More recent research also suggests that  Black/African American, Hispanic/Latinx, and Native Americans were at elevated risk for suicidal ideation if they have a cannabis use disorder and  Black/African American and Hispanic/Latinx groups using cannabis were at higher risk for suicide attempts.

Many of the patients I see have complicated medical problems that can be compounded by cannabis use.  Cannabis has a significant hypotensive effect that typically triggers a rapid heartbeat and "heart pounding effect."  That is a potential problem for people with cardiovascular problems or who take antihypertensive medications.  In a recent large study of 18–44-year-olds, cannabis users (defined as use more than four times a month) were more than twice as likely to experience a heart attack. 

There are better and safer treatments for anxiety disorders. There are better and safer treatments for anxiety disorders that do not respond to first line treatments. I recommend against an anxiety or panic attack indication for medical cannabis because in the vast majority of people I have seen it caused significant anxiety and panic. It also obscures psychiatric diagnoses and considering that most people will not have access to a psychiatrist - will probably result in more medications to treat the cannabis induced symptoms.  At a time when there is more focus on suicide prevention, cannabis use is implicated in suicidal ideation and suicide attempts.  Finally when there has been concern about the lack of medical research on cannabis for positive effects, the negative effects are becoming more apparent. 

 Sincerely,

 

George Dawson, MD, DFAPA

References:

1:  Kelly LM, Drazdowski TK, Livingston NR, Zajac K. Demographic risk factors for co-occurring suicidality and cannabis use disorders: Findings from a nationally representative United States sample. Addict Behav. 2021 Nov;122:107047. doi: 10.1016/j.addbeh.2021.107047. Epub 2021 Jul 12. PMID: 34284313; PMCID: PMC8351371.

2:  Ladha KS, Mistry N, Wijeysundera DN, Clarke H, Verma S, Hare GMT, Mazer CD. Recent cannabis use and myocardial infarction in young adults: a cross-sectional study. CMAJ. 2021 Sep 7;193(35):E1377-E1384. doi: 10.1503/cmaj.202392. PMID: 34493564.

3:  Parekh T, Pemmasani S, Desai R. Marijuana Use Among Young Adults (18-44 Years of Age) and Risk of Stroke: A Behavioral Risk Factor Surveillance System Survey Analysis. Stroke. 2020 Jan;51(1):308-310. doi: 10.1161/STROKEAHA.119.027828. Epub 2019 Nov 11. PMID: 31707926.

4:  Shah S, Patel S, Paulraj S, Chaudhuri D. Association of Marijuana Use and Cardiovascular Disease: A Behavioral Risk Factor Surveillance System Data Analysis of 133,706 US Adults. Am J Med. 2021 May;134(5):614-620.e1. doi: 10.1016/j.amjmed.2020.10.019. Epub 2020 Nov 9. PMID: 33181103.

5:  Desai R, Fong HK, Shah K, Kaur VP, Savani S, Gangani K, Damarlapally N, Goyal H. Rising Trends in Hospitalizations for Cardiovascular Events among Young Cannabis Users (18-39 Years) without Other Substance Abuse. Medicina (Kaunas). 2019 Aug 5;55(8):438. doi: 10.3390/medicina55080438. PMID: 31387198; PMCID: PMC6723728.


Graphic Credit:

Medical Cannabis graphic is from Shutterstock per their standard agreement.